Faricimab-svoa is a new treatment option for nAMD and DME, which can be considered a significant step forward in the management of retinal diseases. This investigational drug performs two significant roles in the progression of the disease; hence, it has potential to help patient by providing enhanced prognosis and lower disease management burden.
Faricimab-Svoa - Uses, Mechanism of Action, Dosage, Warnings, and Side Effects
Faricimab-svoa is a drug used in the management of age-related macular degeneration (AMD). Read the article to know more.
